PEPGEN INC (PEPG:NASDAQ)
$1.64 0.03 (1.8634%)
Analysed PEPGEN INC (PEPG:NASDAQ) News Sources
PepGen Reports Encouraging Phase II FREEDOM2 DM1 Data at 5 mg/kg; 10 mg/kg Cohort Underway
01-04-2026
marketbeat.com
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
30-03-2026
yahoo.com
PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA
05-03-2026
biopharmadive.com
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
04-03-2026
yahoo.com
PepGen Announces Regulatory Updates on FREEDOM2
04-03-2026
yahoo.com
PepGen to Participate in the Leerink Global Healthcare Conference
03-03-2026
yahoo.com
How Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44%
10-12-2025
yahoo.com
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
09-12-2025
yahoo.com
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
08-12-2025
yahoo.com
Sarepta's Stock Rises on Positive Updates on DM1 Therapy
25-11-2025
yahoo.com
What is the current price of PEPGEN INC (PEPG:NASDAQ)?
The current price of PEPGEN INC (PEPG:NASDAQ) is $1.64.
PEPGEN INC (PEPG:NASDAQ) absolute price change since previous trading day?
The absolute price change of PEPGEN INC (PEPG:NASDAQ) since the previous trading day is $0.03.
PEPGEN INC (PEPG:NASDAQ) percentage price change since previous trading day?
The percentage price change of PEPGEN INC (PEPG:NASDAQ) since the previous trading day is 1.8634%.
What is the most recent average sentiment score for PEPGEN INC (PEPG:NASDAQ)?
The most recent average sentiment score for PEPGEN INC (PEPG:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for PEPGEN INC (PEPG:NASDAQ)?
The most recent sentiment for PEPGEN INC (PEPG:NASDAQ) is .
SEC-8K** Filing Available For PEPGEN INC (PEPG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.